REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993,591 | +75458.3% | 60,364 | -8.2% | 0.06% | -19.2% |
| Q2 2023 | $1,315 | -32.0% | 65,789 | -35.7% | 0.08% | -34.5% |
| Q1 2023 | $1,934 | -19.0% | 102,263 | -2.9% | 0.12% | -19.0% |
| Q4 2022 | $2,388 | -99.9% | 105,275 | +12.1% | 0.15% | -9.8% |
| Q3 2022 | $2,481,000 | +12.2% | 93,881 | +4.9% | 0.16% | +19.0% |
| Q2 2022 | $2,211,000 | -2.0% | 89,494 | +31.6% | 0.14% | +14.2% |
| Q1 2022 | $2,257,000 | +28.4% | 68,007 | +26.5% | 0.12% | +39.5% |
| Q4 2021 | $1,758,000 | +35.8% | 53,747 | +74.0% | 0.09% | +26.5% |
| Q3 2021 | $1,295,000 | +64.1% | 30,888 | +52.1% | 0.07% | +61.9% |
| Q2 2021 | $789,000 | – | 20,312 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |